Longitudinal blood pressure control, long-term mortality, and predictive utility of serum liver enzymes and bilirubin in hypertensive patients

Hypertension

Volumn 66, Issue 1, 2015, Pages 37-43

  McCallum, Linsay ^a   Panniyammakal, Jeemon ^a   Hastie, Claire E ^a   Hewitt, Jonathan ^a   Patel, Rajan ^a   Jones, Gregory C ^a   Muir, Scott ^a   Walters, Matthew ^a   Sattar, Naveed ^a   Dominiczak, Anna F ^a   Padmanabhan, Sandosh ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

alkaline phosphatase; aspartate transaminase; bilirubin; hypertension; liver function tests; mortality; glutamyl transpeptidase

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; LIVER ENZYME; BIOLOGICAL MARKER;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD PRESSURE REGULATION; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; HYPERTENSION; LIVER FUNCTION TEST; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE; TERTIARY HEALTH CARE; AGED; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; COMORBIDITY; DRINKING BEHAVIOR; OVERWEIGHT; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; SMOKING; SURVIVAL; UNITED KINGDOM;

ADULT; AGED; ALANINE TRANSAMINASE; ALCOHOL DRINKING; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; BIOMARKERS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; HYPERTENSION; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; OVERWEIGHT; PROPORTIONAL HAZARDS MODELS; SCOTLAND; SMOKING; SURVIVAL ANALYSIS;

EID: 84942743017     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.114.04915     Document Type: Article

References (38)

1. Pratt DS, Kaplan MM., Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med 2000 342 1266 1271. doi: 10.1056/NEJM200004273421707
2. Neuzil J, Stocker R., Free and albumin-bound bilirubin are efficient co-Antioxidants for alpha-Tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J Biol Chem 1994 269 16712 16719
3. Vítek L, Jirsa M, Brodanová M, Kalab M, Marecek Z, Danzig V, Novotný L, Kotal P., Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis 2002 160 449 456
4. Yesilova Z, Serdar M, Ercin CN, Gunay A, Kilciler G, Hasimi A, Uygun A, Kurt I, Erbil MK, Dagalp K., Decreased oxidation susceptibility of plasma low density lipoproteins in patients with Gilbert's syndrome. J Gastroenterol Hepatol 2008 23 1556 1560. doi: 10.1111/j.1440-1746.2008.05388.x
5. Sedlak TW, Saleh M, Higginson DS, Paul BD, Juluri KR, Snyder SH., Bilirubin and glutathione have complementary antioxidant and cytoprotective roles. Proc Natl Acad Sci U S A 2009 106 5171 5176. doi: 10.1073/pnas.0813132106
6. Lin JP, Vitek L, Schwertner HA., Serum bilirubin and genes controlling bilirubin concentrations as biomarkers for cardiovascular disease. Clin Chem 2010 56 1535 1543. doi: 10.1373/clinchem.2010.151043
7. Novotný L, Vítek L., Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-Analysis of published studies. Exp Biol Med (Maywood) 2003 228 568 571
8. Lin JP, O'Donnell CJ, Schwaiger JP, Cupples LA, Lingenhel A, Hunt SC, Yang S, Kronenberg F., Association between the UGT1A1∗28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study. Circulation 2006 114 1476 1481. doi: 10.1161/CIRCULATIONAHA.106.633206
9. Temme EH, Zhang J, Schouten EG, Kesteloot H., Serum bilirubin and 10-year mortality risk in a Belgian population. Cancer Causes Control 2001 12 887 894
10. Horsfall LJ, Rait G, Walters K, Swallow DM, Pereira SP, Nazareth I, Petersen I., Serum bilirubin and risk of respiratory disease and death. JAMA 2011 305 691 697. doi: 10.1001/jama.2011.124
11. Arndt V, Brenner H, Rothenbacher D, Zschenderlein B, Fraisse E, Fliedner TM., Elevated liver enzyme activity in construction workers: prevalence and impact on early retirement and all-cause mortality. Int Arch Occup Environ Health 1998 71 405 412
12. Ford I, Mooijaart SP, Lloyd S, Murray HM, Westendorp RG, de Craen AJ, Packard CJ, Buckley B, Barlow C, Preiss D, Cobbe SM, Stott DJ, Sattar N., The inverse relationship between alanine aminotransferase in the normal range and adverse cardiovascular and non-cardiovascular outcomes. Int J Epidemiol 2011 40 1530 1538. doi: 10.1093/ije/dyr172
13. Nakamura K, Okamura T, Kanda H, Hayakawa T, Okayama A, Ueshima H, Health Promotion Research Committee of the Shiga National Health Insurance Organizations The value of combining serum alanine aminotransferase levels and body mass index to predict mortality and medical costs: a 10-year follow-up study of National Health Insurance in Shiga, Japan. J Epidemiol 2006 16 15 20
14. Ruhl CE, Everhart JE., Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population. Gastroenterology 2009 136 477 85.e11. doi: 10.1053/j.gastro.2008.10.052
15. Kunutsor SK, Apekey TA, Khan H., Liver enzymes and risk of cardiovascular disease in the general population: a meta-Analysis of prospective cohort studies. Atherosclerosis 2014 236 7 17. doi: 10.1016/j.atherosclerosis.2014.06.006
16. Ghouri N, Preiss D, Sattar N., Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data. Hepatology 2010 52 1156 1161. doi: 10.1002/hep.23789
17. Wannamethee G, Ebrahim S, Shaper AG., Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes. Am J Epidemiol 1995 142 699 708
18. Lee DS, Evans JC, Robins SJ, Wilson PW, Albano I, Fox CS, Wang TJ, Benjamin EJ, D'Agostino RB, Vasan RS., Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 2007 27 127 133. doi: 10.1161/01.ATV.0000251993.20372.40
19. Fraser A, Harris R, Sattar N, Ebrahim S, Smith GD, Lawlor DA., Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British Women's Heart and Health Study and Meta-Analysis. Arterioscler Thromb Vasc Biol 2007 27 2729 2735. doi: 10.1161/ATVBAHA.107.152298
20. Pflueger A, Croatt AJ, Peterson TE, Smith LA, d'Uscio LV, Katusic ZS, Nath KA., The hyperbilirubinemic Gunn rat is resistant to the pressor effects of angiotensin II. Am J Physiol Renal Physiol 2005 288 F552 F558. doi: 10.1152/ajprenal.00278.2004
21. Vera T, Granger JP, Stec DE., Inhibition of bilirubin metabolism induces moderate hyperbilirubinemia and attenuates ANG II-dependent hypertension in mice. Am J Physiol Regul Integr Comp Physiol 2009 297 R738 R743. doi: 10.1152/ajpregu.90889.2008
22. Sacerdoti D, Escalante B, Abraham NG, McGiff JC, Levere RD, Schwartzman ML., Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats. Science 1989 243 388 390
23. Stec DE, Drummond HA, Gousette MU, Storm MV, Abraham NG, Csongradi E., Expression of heme oxygenase-1 in thick ascending loop of henle attenuates angiotensin II-dependent hypertension. J Am Soc Nephrol 2012 23 834 841. doi: 10.1681/ASN.2011050455
24. Williamson C, Jeemon P, Hastie CE, McCallum L, Muir S, Dawson J, Walters M, Sloan W, Morrison D, Dominiczak AF, Pell J, Padmanabhan S., Family history of premature cardiovascular disease: blood pressure control and long-Term mortality outcomes in hypertensive patients. Eur Heart J 2014 35 563 570. doi: 10.1093/eurheartj/eht539
25. Grambsch PM, Therneau TM, Fleming TR., Diagnostic plots to reveal functional form for covariates in multiplicative intensity models. Biometrics 1995 51 1469 1482
26. Hanley JA, Negassa A, Edwardes MD, Forrester JE., Statistical analysis of correlated data using generalized estimating equations: an orientation. Am J Epidemiol 2003 157 364 375
27. Frei B, Stocker R, Ames BN., Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci U S A 1988 85 9748 9752
28. Wang H, Garvin JL, D'Ambrosio MA, Falck JR, Leung P, Liu R, Ren Y, Carretero OA., Heme oxygenase metabolites inhibit tubuloglomerular feedback in vivo. Am J Physiol Heart Circ Physiol 2011 300 H1320 H1326. doi: 10.1152/ajpheart.01118.2010
29. Stocker R, Glazer AN, Ames BN., Antioxidant activity of albumin-bound bilirubin. Proc Natl Acad Sci U S A 1987 84 5918 5922
30. Dunn W, Xu R, Wingard DL, Rogers C, Angulo P, Younossi ZM, Schwimmer JB., Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. Am J Gastroenterol 2008 103 2263 2271. doi: 10.1111/j.1572-0241.2008.02034.x
31. Lee TH, Kim WR, Benson JT, Therneau TM, Melton LJ III, Serum aminotransferase activity and mortality risk in a United States community. Hepatology 2008 47 880 887. doi: 10.1002/hep.22090
32. Yun KE, Shin CY, Yoon YS, Park HS., Elevated alanine aminotransferase levels predict mortality from cardiovascular disease and diabetes in Koreans. Atherosclerosis 2009 205 533 537. doi: 10.1016/j.atherosclerosis.2008.12.012
33. Le Couteur DG, Blyth FM, Creasey HM, Handelsman DJ, Naganathan V, Sambrook PN, Seibel MJ, Waite LM, Cumming RG., The association of alanine transaminase with aging, frailty, and mortality. J Gerontol A Biol Sci Med Sci 2010 65 712 717. doi: 10.1093/gerona/glq082
34. Elinav E, Ben-Dov IZ, Ackerman E, Kiderman A, Glikberg F, Shapira Y, Ackerman Z., Correlation between serum alanine aminotransferase activity and age: an inverted U curve pattern. Am J Gastroenterol 2005 100 2201 2204. doi: 10.1111/j.1572-0241.2005.41822.x
35. Whitfield JB., Gamma glutamyl transferase. Crit Rev Clin Lab Sci 2001 38 263 355. doi: 10.1080/20014091084227
36. Fraser A, Harris R, Sattar N, Ebrahim S, Davey Smith G, Lawlor DA., Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-Analysis. Diabetes Care 2009 32 741 750. doi: 10.2337/dc08-1870
37. Mason JE, Starke RD, Van Kirk JE., Gamma-glutamyl transferase: a novel cardiovascular risk biomarker. Prev Cardiol 2010 13 36 41. doi: 10.1111/j.1751-7141.2009.00054.x
38. Cook NR, Ridker PM., Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures. Ann Intern Med 2009 150 795 802